

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.01329364 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.01329364 |
| 3 | behavioral response to nicotine (GO:0035095) | 6.85626762 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.78030323 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.78030323 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.26409452 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.68922207 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.65877568 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.65877568 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.65877568 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.59141032 |
| 12 | urea metabolic process (GO:0019627) | 5.47135707 |
| 13 | urea cycle (GO:0000050) | 5.47135707 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.37886343 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.34401548 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.25265566 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.22933595 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.19133987 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.18733625 |
| 20 | fucose catabolic process (GO:0019317) | 5.14275324 |
| 21 | L-fucose metabolic process (GO:0042354) | 5.14275324 |
| 22 | L-fucose catabolic process (GO:0042355) | 5.14275324 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.03773881 |
| 24 | protein carboxylation (GO:0018214) | 5.03773881 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.97303504 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 4.86113898 |
| 27 | cysteine metabolic process (GO:0006534) | 4.83089329 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.82956051 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.81717528 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.75872835 |
| 31 | bile acid metabolic process (GO:0008206) | 4.70719763 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.63219342 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.60954221 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.60325051 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 4.53070005 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.52169916 |
| 37 | lysine metabolic process (GO:0006553) | 4.52147074 |
| 38 | lysine catabolic process (GO:0006554) | 4.52147074 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.51376975 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.51376975 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.51376975 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.49612915 |
| 43 | regulation of complement activation (GO:0030449) | 4.49567788 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 4.49313102 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.48856196 |
| 46 | phospholipid efflux (GO:0033700) | 4.45440233 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.32529386 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.31103358 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.31103358 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.28838215 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.28838215 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.23909387 |
| 53 | regulation of cholesterol homeostasis (GO:2000188) | 4.22422378 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.20639299 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.18657608 |
| 56 | glutamate metabolic process (GO:0006536) | 4.18352706 |
| 57 | positive regulation of CREB transcription factor activity (GO:0032793) | 4.16013243 |
| 58 | cellular modified amino acid catabolic process (GO:0042219) | 4.13431031 |
| 59 | drug catabolic process (GO:0042737) | 4.11791560 |
| 60 | regulation of hippo signaling (GO:0035330) | 4.10516261 |
| 61 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09067633 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.04099506 |
| 63 | glycine metabolic process (GO:0006544) | 4.01942421 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 4.01001235 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 3.96802697 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.96599370 |
| 67 | regulation of gene silencing by RNA (GO:0060966) | 3.94835596 |
| 68 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.94835596 |
| 69 | regulation of gene silencing by miRNA (GO:0060964) | 3.94835596 |
| 70 | phospholipid homeostasis (GO:0055091) | 3.93290770 |
| 71 | low-density lipoprotein particle remodeling (GO:0034374) | 3.92329496 |
| 72 | cholesterol efflux (GO:0033344) | 3.88941699 |
| 73 | cellular response to ATP (GO:0071318) | 3.82845167 |
| 74 | positive regulation of fatty acid oxidation (GO:0046321) | 3.80617153 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.77122226 |
| 76 | ethanol oxidation (GO:0006069) | 3.76302597 |
| 77 | cellular glucuronidation (GO:0052695) | 3.75723850 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.75519764 |
| 79 | amine catabolic process (GO:0009310) | 3.74216015 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 3.74216015 |
| 81 | arginine metabolic process (GO:0006525) | 3.72803480 |
| 82 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68961261 |
| 83 | sulfation (GO:0051923) | 3.66733763 |
| 84 | exogenous drug catabolic process (GO:0042738) | 3.64758298 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 3.63803587 |
| 86 | 2-oxoglutarate metabolic process (GO:0006103) | 3.62614140 |
| 87 | ketone body metabolic process (GO:1902224) | 3.59395110 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 3.59356114 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 3.57735926 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.55746167 |
| 91 | primary amino compound metabolic process (GO:1901160) | 3.55484734 |
| 92 | negative regulation of lipase activity (GO:0060192) | 3.52568876 |
| 93 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.50879750 |
| 94 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.50879750 |
| 95 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.50879750 |
| 96 | fibrinolysis (GO:0042730) | 3.49824897 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.48797747 |
| 98 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.48604777 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.46878414 |
| 100 | organic acid catabolic process (GO:0016054) | 3.46878414 |
| 101 | drug transmembrane transport (GO:0006855) | 3.46308490 |
| 102 | valine metabolic process (GO:0006573) | 3.44813444 |
| 103 | cytolysis (GO:0019835) | 3.44650563 |
| 104 | indole-containing compound metabolic process (GO:0042430) | 3.42303664 |
| 105 | plasma lipoprotein particle organization (GO:0071827) | 3.41628701 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.40924464 |
| 107 | epoxygenase P450 pathway (GO:0019373) | 3.40755425 |
| 108 | acetyl-CoA metabolic process (GO:0006084) | 3.39470748 |
| 109 | serine family amino acid biosynthetic process (GO:0009070) | 3.39450141 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.38724448 |
| 111 | sterol homeostasis (GO:0055092) | 3.38336790 |
| 112 | nephron epithelium morphogenesis (GO:0072088) | 3.38093659 |
| 113 | nephron tubule morphogenesis (GO:0072078) | 3.38093659 |
| 114 | serotonin metabolic process (GO:0042428) | 3.37944759 |
| 115 | fucosylation (GO:0036065) | 3.37169336 |
| 116 | urate metabolic process (GO:0046415) | 3.33271807 |
| 117 | NAD biosynthetic process (GO:0009435) | 3.31973797 |
| 118 | cellular response to exogenous dsRNA (GO:0071360) | 3.31819457 |
| 119 | uronic acid metabolic process (GO:0006063) | 3.30575805 |
| 120 | glucuronate metabolic process (GO:0019585) | 3.30575805 |
| 121 | complement activation, classical pathway (GO:0006958) | 3.30114350 |
| 122 | carnitine metabolic process (GO:0009437) | 3.29088291 |
| 123 | neuronal action potential (GO:0019228) | 3.28571614 |
| 124 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.27764891 |
| 125 | gamma-aminobutyric acid transport (GO:0015812) | 3.26942180 |
| 126 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.24319326 |
| 127 | interkinetic nuclear migration (GO:0022027) | 3.22480429 |
| 128 | endosome to pigment granule transport (GO:0043485) | 3.22228407 |
| 129 | endosome to melanosome transport (GO:0035646) | 3.22228407 |
| 130 | macroautophagy (GO:0016236) | 3.11151842 |
| 131 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.08572206 |
| 132 | cAMP catabolic process (GO:0006198) | 3.05397343 |
| 133 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.04560301 |
| 134 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.04560301 |
| 135 | cardiovascular system development (GO:0072358) | 2.98914548 |
| 136 | striated muscle atrophy (GO:0014891) | 2.93789370 |
| 137 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.92970831 |
| 138 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.90171511 |
| 139 | flavonoid metabolic process (GO:0009812) | 2.89500022 |
| 140 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.89237722 |
| 141 | detection of light stimulus involved in visual perception (GO:0050908) | 2.89237722 |
| 142 | histone-serine phosphorylation (GO:0035404) | 2.83500430 |
| 143 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.82569031 |
| 144 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.82551997 |
| 145 | sulfate transmembrane transport (GO:1902358) | 2.80448222 |
| 146 | snRNA transcription (GO:0009301) | 2.79763648 |
| 147 | oxidative demethylation (GO:0070989) | 2.79693553 |
| 148 | negative regulation of sodium ion transport (GO:0010766) | 2.79461249 |
| 149 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.78714101 |
| 150 | protein K48-linked deubiquitination (GO:0071108) | 2.73186312 |
| 151 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.69248926 |
| 152 | positive regulation of fatty acid transport (GO:2000193) | 2.68947494 |
| 153 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.68726531 |
| 154 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.67310128 |
| 155 | peristalsis (GO:0030432) | 2.66209881 |
| 156 | neurotransmitter metabolic process (GO:0042133) | 2.65585274 |
| 157 | behavioral response to ethanol (GO:0048149) | 2.65294657 |
| 158 | cyclic nucleotide catabolic process (GO:0009214) | 2.64339653 |
| 159 | positive regulation of developmental pigmentation (GO:0048087) | 2.62515185 |
| 160 | sulfate transport (GO:0008272) | 2.62338578 |
| 161 | reflex (GO:0060004) | 2.60388224 |
| 162 | spinal cord motor neuron differentiation (GO:0021522) | 2.59380346 |
| 163 | response to pheromone (GO:0019236) | 2.57799552 |
| 164 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.56348053 |
| 165 | alkaloid metabolic process (GO:0009820) | 2.53159570 |
| 166 | regulation of pigment cell differentiation (GO:0050932) | 2.52439157 |
| 167 | cornea development in camera-type eye (GO:0061303) | 2.51978799 |
| 168 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.51539387 |
| 169 | renal tubule morphogenesis (GO:0061333) | 2.50773097 |
| 170 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.49853482 |
| 171 | regulation of histone phosphorylation (GO:0033127) | 2.49656701 |
| 172 | membrane depolarization during action potential (GO:0086010) | 2.49490240 |
| 173 | skeletal muscle adaptation (GO:0043501) | 2.48983460 |
| 174 | urinary tract smooth muscle contraction (GO:0014848) | 2.48534925 |
| 175 | opioid receptor signaling pathway (GO:0038003) | 2.48434735 |
| 176 | positive regulation of protein kinase C signaling (GO:0090037) | 2.47960225 |
| 177 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.47689256 |
| 178 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.47689256 |
| 179 | negative regulation of telomere maintenance (GO:0032205) | 2.46590996 |
| 180 | rRNA catabolic process (GO:0016075) | 2.46506213 |
| 181 | synaptic transmission, cholinergic (GO:0007271) | 2.43526674 |
| 182 | regulation of action potential (GO:0098900) | 2.41691109 |
| 183 | basic amino acid transport (GO:0015802) | 2.41450300 |
| 184 | regulation of establishment of cell polarity (GO:2000114) | 2.40772373 |
| 185 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.39516042 |
| 186 | kidney morphogenesis (GO:0060993) | 2.39200352 |
| 187 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.39012079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.57801499 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.66011368 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.02158528 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.36065308 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.92475007 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.54148723 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.48809969 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.99191450 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93609514 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.67937125 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.06207401 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.65995127 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.65418103 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.54144342 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.51934400 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.19957544 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.13867132 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12372534 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03139507 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5273554 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.89674905 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86291921 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85138234 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82783201 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80735253 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71863887 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67720965 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67023235 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61080004 |
| 30 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57565628 |
| 31 | TP53_16413492_ChIP-PET_HCT116_Human | 1.57371343 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56108646 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.54229166 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51893970 |
| 35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.49781489 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47318408 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46552351 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46408548 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.46069729 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45379174 |
| 41 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44266459 |
| 42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.43747819 |
| 43 | STAT3_23295773_ChIP-Seq_U87_Human | 1.43355239 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42464861 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41180807 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40743309 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40632671 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40272649 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39997916 |
| 50 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38984346 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38914256 |
| 52 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38884297 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34427819 |
| 54 | ERA_21632823_ChIP-Seq_H3396_Human | 1.34184231 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33177468 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.32923628 |
| 57 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32887748 |
| 58 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32887748 |
| 59 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.31370147 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30913396 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28082907 |
| 62 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.27233367 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24428745 |
| 64 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22807887 |
| 65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22158341 |
| 66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20968586 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20157170 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19756034 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19715637 |
| 70 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.19633827 |
| 71 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.19633827 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19475863 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17547128 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17489356 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16835204 |
| 76 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12758372 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11014414 |
| 78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10280742 |
| 79 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10094118 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08902671 |
| 81 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.08668074 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08189015 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07728445 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07596994 |
| 85 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.06575370 |
| 86 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.06407643 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05974825 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05906000 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05640703 |
| 90 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05468295 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04812994 |
| 92 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.04236502 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03812475 |
| 94 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.03466906 |
| 95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03386850 |
| 96 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02702444 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02501785 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02314550 |
| 99 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01896291 |
| 100 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.00190858 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00026682 |
| 102 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.99718569 |
| 103 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.99066369 |
| 104 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99049124 |
| 105 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 0.98813710 |
| 106 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98459252 |
| 107 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.98382307 |
| 108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94985381 |
| 109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94416995 |
| 110 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94223497 |
| 111 | * AR_19668381_ChIP-Seq_PC3_Human | 0.93820581 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93783077 |
| 113 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93528115 |
| 114 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93501804 |
| 115 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92465176 |
| 116 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.92216789 |
| 117 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92207758 |
| 118 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92045914 |
| 119 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90181796 |
| 120 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.90066581 |
| 121 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.90066581 |
| 122 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89994346 |
| 123 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89219887 |
| 124 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89062791 |
| 125 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89048526 |
| 126 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88724425 |
| 127 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88368956 |
| 128 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.88003329 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86338267 |
| 130 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85468290 |
| 131 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85350259 |
| 132 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84562425 |
| 133 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84165613 |
| 134 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82081307 |
| 135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81382656 |
| 136 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80439504 |
| 137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78991540 |
| 138 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78654707 |
| 139 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77772591 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77368841 |
| 141 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75794785 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75251852 |
| 143 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74851377 |
| 144 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74841600 |
| 145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.73292639 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72935562 |
| 147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72496577 |
| 148 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.71713338 |
| 149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70894781 |
| 150 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69811347 |
| 151 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69720177 |
| 152 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69234970 |
| 153 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68072668 |
| 154 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.67755724 |
| 155 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.67496549 |
| 156 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67401894 |
| 157 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66172663 |
| 158 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65719118 |
| 159 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.65629124 |
| 160 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65329243 |
| 161 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63397373 |
| 162 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.63050551 |
| 163 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.62759373 |
| 164 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.62461943 |
| 165 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60200460 |
| 166 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59836860 |
| 167 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.59221601 |
| 168 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.59221601 |
| 169 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.58208406 |
| 170 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57185736 |
| 171 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56209345 |
| 172 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.56175128 |
| 173 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55864198 |
| 174 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55864198 |
| 175 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55727675 |
| 176 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.55211553 |
| 177 | KDM2B_26808549_Chip-Seq_K562_Human | 0.54196662 |
| 178 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.52732939 |
| 179 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.52404403 |
| 180 | ATF3_27146783_Chip-Seq_COLON_Human | 0.52039770 |
| 181 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.51689359 |
| 182 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.51643941 |
| 183 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.51367723 |
| 184 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.50855360 |
| 185 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.50715342 |
| 186 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50221888 |
| 187 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.50093399 |
| 188 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.49174423 |
| 189 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.49123110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.42583455 |
| 2 | MP0005360_urolithiasis | 6.78512762 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.10741884 |
| 4 | MP0005365_abnormal_bile_salt | 5.96849550 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.88964431 |
| 6 | MP0003252_abnormal_bile_duct | 3.79973241 |
| 7 | MP0003136_yellow_coat_color | 3.49407570 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.46601647 |
| 9 | MP0005083_abnormal_biliary_tract | 3.32790829 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.31180632 |
| 11 | MP0009840_abnormal_foam_cell | 3.05436968 |
| 12 | MP0000569_abnormal_digit_pigmentation | 3.01598200 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.78536950 |
| 14 | MP0003646_muscle_fatigue | 2.68011870 |
| 15 | MP0005332_abnormal_amino_acid | 2.65898563 |
| 16 | MP0005174_abnormal_tail_pigmentation | 2.61909645 |
| 17 | MP0003195_calcinosis | 2.58788865 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.41418367 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.32961297 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.29471705 |
| 21 | MP0008872_abnormal_physiological_respon | 2.28491019 |
| 22 | MP0003868_abnormal_feces_composition | 2.27879280 |
| 23 | MP0009046_muscle_twitch | 2.22106931 |
| 24 | MP0000609_abnormal_liver_physiology | 2.17142981 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.16703608 |
| 26 | MP0009745_abnormal_behavioral_response | 2.14426292 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.13635502 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 2.08415162 |
| 29 | MP0001501_abnormal_sleep_pattern | 2.02526626 |
| 30 | MP0005171_absent_coat_pigmentation | 2.00527608 |
| 31 | MP0001873_stomach_inflammation | 2.00259863 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 2.00217987 |
| 33 | MP0000427_abnormal_hair_cycle | 1.96514388 |
| 34 | MP0004142_abnormal_muscle_tone | 1.95260623 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.93993170 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.93681337 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.85276425 |
| 38 | MP0002064_seizures | 1.82410539 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.74383702 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.67333030 |
| 41 | MP0004885_abnormal_endolymph | 1.66619586 |
| 42 | MP0002254_reproductive_system_inflammat | 1.65342733 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.62355933 |
| 44 | MP0004133_heterotaxia | 1.62118023 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.61149150 |
| 46 | MP0004147_increased_porphyrin_level | 1.59573014 |
| 47 | MP0002272_abnormal_nervous_system | 1.58925890 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.57727660 |
| 49 | MP0002063_abnormal_learning/memory/cond | 1.57275845 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.55108726 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.53574434 |
| 52 | MP0002572_abnormal_emotion/affect_behav | 1.53346945 |
| 53 | MP0001664_abnormal_digestion | 1.46678123 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.43607269 |
| 55 | MP0001970_abnormal_pain_threshold | 1.42221744 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 1.42043122 |
| 57 | MP0002733_abnormal_thermal_nociception | 1.39381231 |
| 58 | MP0003283_abnormal_digestive_organ | 1.39104980 |
| 59 | MP0005451_abnormal_body_composition | 1.37513619 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.37273751 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.37210025 |
| 62 | MP0000470_abnormal_stomach_morphology | 1.33071044 |
| 63 | MP0004742_abnormal_vestibular_system | 1.32873991 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32080432 |
| 65 | MP0004924_abnormal_behavior | 1.31488877 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.31488877 |
| 67 | MP0005423_abnormal_somatic_nervous | 1.31391452 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.30618222 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 1.27475553 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.25216604 |
| 71 | MP0001764_abnormal_homeostasis | 1.24549436 |
| 72 | MP0003890_abnormal_embryonic-extraembry | 1.23465830 |
| 73 | MP0000598_abnormal_liver_morphology | 1.22083793 |
| 74 | MP0002736_abnormal_nociception_after | 1.21055031 |
| 75 | MP0002557_abnormal_social/conspecific_i | 1.20292560 |
| 76 | MP0004145_abnormal_muscle_electrophysio | 1.18463381 |
| 77 | MP0001486_abnormal_startle_reflex | 1.18019327 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 1.17419309 |
| 79 | MP0001663_abnormal_digestive_system | 1.16272152 |
| 80 | MP0009697_abnormal_copulation | 1.14866207 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 1.13688423 |
| 82 | MP0001919_abnormal_reproductive_system | 1.08930853 |
| 83 | MP0000383_abnormal_hair_follicle | 1.07847773 |
| 84 | MP0008877_abnormal_DNA_methylation | 1.07702960 |
| 85 | MP0003119_abnormal_digestive_system | 1.07634410 |
| 86 | MP0002938_white_spotting | 1.07128204 |
| 87 | MP0002734_abnormal_mechanical_nocicepti | 1.05705422 |
| 88 | MP0002160_abnormal_reproductive_system | 1.05148230 |
| 89 | MP0001756_abnormal_urination | 1.04828318 |
| 90 | MP0000778_abnormal_nervous_system | 1.03050442 |
| 91 | MP0003632_abnormal_nervous_system | 0.99774503 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.98306084 |
| 93 | MP0000604_amyloidosis | 0.94760857 |
| 94 | MP0000026_abnormal_inner_ear | 0.94456246 |
| 95 | MP0005389_reproductive_system_phenotype | 0.94195064 |
| 96 | MP0003045_fibrosis | 0.94074867 |
| 97 | MP0004130_abnormal_muscle_cell | 0.93584002 |
| 98 | MP0005647_abnormal_sex_gland | 0.92869044 |
| 99 | MP0000566_synostosis | 0.91574411 |
| 100 | MP0003879_abnormal_hair_cell | 0.90041550 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.89980051 |
| 102 | MP0002796_impaired_skin_barrier | 0.88575510 |
| 103 | MP0005195_abnormal_posterior_eye | 0.87018469 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.86675590 |
| 105 | MP0005670_abnormal_white_adipose | 0.86313490 |
| 106 | MP0009764_decreased_sensitivity_to | 0.85635411 |
| 107 | MP0005310_abnormal_salivary_gland | 0.85475179 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.85012954 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.84843823 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.84836830 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.84802810 |
| 112 | MP0003011_delayed_dark_adaptation | 0.83833037 |
| 113 | MP0002095_abnormal_skin_pigmentation | 0.83185052 |
| 114 | MP0009763_increased_sensitivity_to | 0.82889189 |
| 115 | MP0001440_abnormal_grooming_behavior | 0.80685179 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.79945212 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.79855352 |
| 118 | MP0002102_abnormal_ear_morphology | 0.78988066 |
| 119 | MP0003878_abnormal_ear_physiology | 0.78905734 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.78905734 |
| 121 | MP0004043_abnormal_pH_regulation | 0.78832297 |
| 122 | MP0005334_abnormal_fat_pad | 0.78222513 |
| 123 | MP0000685_abnormal_immune_system | 0.75157493 |
| 124 | MP0008469_abnormal_protein_level | 0.74413370 |
| 125 | MP0002009_preneoplasia | 0.73933445 |
| 126 | MP0001324_abnormal_eye_pigmentation | 0.73814485 |
| 127 | MP0000955_abnormal_spinal_cord | 0.73640665 |
| 128 | MP0005448_abnormal_energy_balance | 0.72971857 |
| 129 | MP0009780_abnormal_chondrocyte_physiolo | 0.72882884 |
| 130 | MP0002752_abnormal_somatic_nervous | 0.72118774 |
| 131 | MP0005535_abnormal_body_temperature | 0.71659234 |
| 132 | MP0002928_abnormal_bile_duct | 0.71574448 |
| 133 | MP0003300_gastrointestinal_ulcer | 0.68329118 |
| 134 | MP0001881_abnormal_mammary_gland | 0.66933795 |
| 135 | MP0000579_abnormal_nail_morphology | 0.66615231 |
| 136 | MP0002971_abnormal_brown_adipose | 0.66477807 |
| 137 | MP0003186_abnormal_redox_activity | 0.66191500 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.63945464 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.63943790 |
| 140 | MP0001765_abnormal_ion_homeostasis | 0.59998757 |
| 141 | MP0003953_abnormal_hormone_level | 0.59647750 |
| 142 | MP0002136_abnormal_kidney_physiology | 0.59011508 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.58072317 |
| 144 | MP0008961_abnormal_basal_metabolism | 0.57399313 |
| 145 | MP0002909_abnormal_adrenal_gland | 0.57390054 |
| 146 | MP0005408_hypopigmentation | 0.56856983 |
| 147 | MP0002060_abnormal_skin_morphology | 0.56086468 |
| 148 | MP0001661_extended_life_span | 0.55486356 |
| 149 | MP0003329_amyloid_beta_deposits | 0.54945956 |
| 150 | MP0003638_abnormal_response/metabolism_ | 0.54524105 |
| 151 | MP0008874_decreased_physiological_sensi | 0.54428108 |
| 152 | MP0005376_homeostasis/metabolism_phenot | 0.53922702 |
| 153 | MP0009672_abnormal_birth_weight | 0.53280086 |
| 154 | MP0002822_catalepsy | 0.53111896 |
| 155 | MP0005666_abnormal_adipose_tissue | 0.52688498 |
| 156 | MP0000639_abnormal_adrenal_gland | 0.52483165 |
| 157 | MP0005187_abnormal_penis_morphology | 0.51011411 |
| 158 | MP0005248_abnormal_Harderian_gland | 0.49974589 |
| 159 | MP0002837_dystrophic_cardiac_calcinosis | 0.49461703 |
| 160 | MP0009053_abnormal_anal_canal | 0.49253204 |
| 161 | MP0004947_skin_inflammation | 0.48074435 |
| 162 | MP0000538_abnormal_urinary_bladder | 0.47818478 |
| 163 | MP0010386_abnormal_urinary_bladder | 0.47325652 |
| 164 | MP0006036_abnormal_mitochondrial_physio | 0.47193764 |
| 165 | MP0005266_abnormal_metabolism | 0.45945427 |
| 166 | MP0000230_abnormal_systemic_arterial | 0.44426607 |
| 167 | MP0005464_abnormal_platelet_physiology | 0.41881255 |
| 168 | MP0004185_abnormal_adipocyte_glucose | 0.41809345 |
| 169 | MP0003959_abnormal_lean_body | 0.40879514 |
| 170 | MP0009384_cardiac_valve_regurgitation | 0.39682573 |
| 171 | MP0005395_other_phenotype | 0.38619226 |
| 172 | MP0001243_abnormal_dermal_layer | 0.38330565 |
| 173 | MP0003943_abnormal_hepatobiliary_system | 0.38160278 |
| 174 | MP0009115_abnormal_fat_cell | 0.37542729 |
| 175 | MP0005167_abnormal_blood-brain_barrier | 0.36792708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.89165427 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.80478119 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.57337906 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.22600292 |
| 5 | Xanthomatosis (HP:0000991) | 5.64352057 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.53392933 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.43798285 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.81470316 |
| 9 | Complement deficiency (HP:0004431) | 4.67243640 |
| 10 | Genetic anticipation (HP:0003743) | 4.64998332 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.60627547 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.41145836 |
| 13 | Ketosis (HP:0001946) | 4.40953401 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.33675540 |
| 15 | Birth length less than 3rd percentile (HP:0003561) | 4.28197281 |
| 16 | Hyperventilation (HP:0002883) | 4.26317450 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.20586811 |
| 18 | Epidermoid cyst (HP:0200040) | 4.20098022 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.15767185 |
| 20 | Hyperammonemia (HP:0001987) | 4.12763868 |
| 21 | Hyperglycinemia (HP:0002154) | 4.06834018 |
| 22 | Joint hemorrhage (HP:0005261) | 4.00501695 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.94660054 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.88714727 |
| 25 | Hyperglycinuria (HP:0003108) | 3.87311930 |
| 26 | Congenital stationary night blindness (HP:0007642) | 3.85784358 |
| 27 | Abnormality of alanine metabolism (HP:0010916) | 3.82343061 |
| 28 | Hyperalaninemia (HP:0003348) | 3.82343061 |
| 29 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.82343061 |
| 30 | Clumsiness (HP:0002312) | 3.80090757 |
| 31 | Pancreatic cysts (HP:0001737) | 3.79197249 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 3.78573915 |
| 33 | Type II lissencephaly (HP:0007260) | 3.75217898 |
| 34 | Protruding tongue (HP:0010808) | 3.74639647 |
| 35 | Ketoacidosis (HP:0001993) | 3.73590915 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.72010249 |
| 37 | Fat malabsorption (HP:0002630) | 3.70986077 |
| 38 | Molar tooth sign on MRI (HP:0002419) | 3.67073239 |
| 39 | Abnormality of midbrain morphology (HP:0002418) | 3.67073239 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.63761332 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 3.63439592 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63439592 |
| 43 | Hypoglycemic seizures (HP:0002173) | 3.52488061 |
| 44 | Patellar aplasia (HP:0006443) | 3.52429185 |
| 45 | Progressive cerebellar ataxia (HP:0002073) | 3.50156464 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.47860148 |
| 47 | Abnormality of complement system (HP:0005339) | 3.45531785 |
| 48 | Large for gestational age (HP:0001520) | 3.45106930 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 3.43244271 |
| 50 | Decreased circulating renin level (HP:0003351) | 3.42450054 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.35744288 |
| 52 | Cerebellar dysplasia (HP:0007033) | 3.28736425 |
| 53 | Attenuation of retinal blood vessels (HP:0007843) | 3.26462105 |
| 54 | Inability to walk (HP:0002540) | 3.24047067 |
| 55 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.23927437 |
| 56 | Hypercholesterolemia (HP:0003124) | 3.19758141 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.16126605 |
| 58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.15378866 |
| 59 | Tubular atrophy (HP:0000092) | 3.09380273 |
| 60 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.09144978 |
| 61 | Nephronophthisis (HP:0000090) | 3.05422243 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04684267 |
| 63 | Pancreatic fibrosis (HP:0100732) | 3.04643658 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.96308496 |
| 65 | Skin nodule (HP:0200036) | 2.96075169 |
| 66 | Gout (HP:0001997) | 2.93868131 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 2.91539234 |
| 68 | True hermaphroditism (HP:0010459) | 2.90955993 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 2.89890255 |
| 70 | Abnormality of the pons (HP:0007361) | 2.89353829 |
| 71 | Hypoplasia of the pons (HP:0012110) | 2.88987025 |
| 72 | Hyperbilirubinemia (HP:0002904) | 2.88959069 |
| 73 | Hyperglycemia (HP:0003074) | 2.87565882 |
| 74 | Breast hypoplasia (HP:0003187) | 2.87447424 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.85853960 |
| 76 | Late onset (HP:0003584) | 2.82732899 |
| 77 | Spontaneous abortion (HP:0005268) | 2.69271980 |
| 78 | Progressive inability to walk (HP:0002505) | 2.68633896 |
| 79 | Cystic liver disease (HP:0006706) | 2.67978105 |
| 80 | Abnormality of the renal medulla (HP:0100957) | 2.65790714 |
| 81 | Myocardial infarction (HP:0001658) | 2.62389839 |
| 82 | Gaze-evoked nystagmus (HP:0000640) | 2.61154006 |
| 83 | Symptomatic seizures (HP:0011145) | 2.60478960 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 2.60458996 |
| 85 | Chronic hepatic failure (HP:0100626) | 2.57806062 |
| 86 | Steatorrhea (HP:0002570) | 2.56695833 |
| 87 | Pendular nystagmus (HP:0012043) | 2.56323821 |
| 88 | Chorioretinal atrophy (HP:0000533) | 2.55962419 |
| 89 | Mitral stenosis (HP:0001718) | 2.53728751 |
| 90 | Furrowed tongue (HP:0000221) | 2.53608991 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 2.52703341 |
| 92 | Concave nail (HP:0001598) | 2.50820069 |
| 93 | Metabolic acidosis (HP:0001942) | 2.50607392 |
| 94 | Partial agenesis of the corpus callosum (HP:0001338) | 2.48621308 |
| 95 | Spastic diplegia (HP:0001264) | 2.47610844 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 2.46463512 |
| 97 | Irritability (HP:0000737) | 2.45049047 |
| 98 | Abnormality of the renal cortex (HP:0011035) | 2.41542078 |
| 99 | Neonatal onset (HP:0003623) | 2.40992155 |
| 100 | Severe muscular hypotonia (HP:0006829) | 2.39678752 |
| 101 | Esophageal varix (HP:0002040) | 2.39234094 |
| 102 | Vascular calcification (HP:0004934) | 2.37261961 |
| 103 | Malnutrition (HP:0004395) | 2.34181860 |
| 104 | Congenital, generalized hypertrichosis (HP:0004540) | 2.32643625 |
| 105 | Broad-based gait (HP:0002136) | 2.32478653 |
| 106 | Lissencephaly (HP:0001339) | 2.32262524 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 2.31842862 |
| 108 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31842862 |
| 109 | Polydipsia (HP:0001959) | 2.29603223 |
| 110 | Abnormal drinking behavior (HP:0030082) | 2.29603223 |
| 111 | Systemic lupus erythematosus (HP:0002725) | 2.29241753 |
| 112 | Fair hair (HP:0002286) | 2.28959012 |
| 113 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.27209774 |
| 114 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.27209774 |
| 115 | Duplicated collecting system (HP:0000081) | 2.25698009 |
| 116 | Abnormality of proline metabolism (HP:0010907) | 2.23487372 |
| 117 | Hydroxyprolinuria (HP:0003080) | 2.23487372 |
| 118 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.23457476 |
| 119 | Abnormality of renin-angiotensin system (HP:0000847) | 2.20918031 |
| 120 | Abnormal gallbladder morphology (HP:0012437) | 2.20444430 |
| 121 | Mesangial abnormality (HP:0001966) | 2.19823326 |
| 122 | Generalized aminoaciduria (HP:0002909) | 2.19292148 |
| 123 | Menorrhagia (HP:0000132) | 2.18563776 |
| 124 | Hypoplastic ischia (HP:0003175) | 2.16627950 |
| 125 | Bulbous nose (HP:0000414) | 2.16101204 |
| 126 | Bronchomalacia (HP:0002780) | 2.15544629 |
| 127 | Sensorimotor neuropathy (HP:0007141) | 2.14016145 |
| 128 | Febrile seizures (HP:0002373) | 2.13800358 |
| 129 | Keratoconus (HP:0000563) | 2.13789936 |
| 130 | Increased corneal curvature (HP:0100692) | 2.13789936 |
| 131 | Gingival bleeding (HP:0000225) | 2.13422953 |
| 132 | Abnormality of the renal collecting system (HP:0004742) | 2.09786056 |
| 133 | Lethargy (HP:0001254) | 2.09664343 |
| 134 | Cardiovascular calcification (HP:0011915) | 2.09058193 |
| 135 | Pancreatitis (HP:0001733) | 2.08255549 |
| 136 | Metabolic alkalosis (HP:0200114) | 2.07802805 |
| 137 | Cholelithiasis (HP:0001081) | 2.07621540 |
| 138 | Acanthocytosis (HP:0001927) | 2.06792469 |
| 139 | Glomerulonephritis (HP:0000099) | 2.03558378 |
| 140 | Rib fusion (HP:0000902) | 2.02569678 |
| 141 | Abolished electroretinogram (ERG) (HP:0000550) | 2.00740047 |
| 142 | Macroglossia (HP:0000158) | 1.98698210 |
| 143 | Tachypnea (HP:0002789) | 1.97411099 |
| 144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.97340694 |
| 145 | Thrombophlebitis (HP:0004418) | 1.96643207 |
| 146 | Generalized hypopigmentation of hair (HP:0011358) | 1.95453267 |
| 147 | Global brain atrophy (HP:0002283) | 1.95194113 |
| 148 | Broad metatarsal (HP:0001783) | 1.93548089 |
| 149 | Alkalosis (HP:0001948) | 1.89914375 |
| 150 | Amelogenesis imperfecta (HP:0000705) | 1.89536549 |
| 151 | Impaired smooth pursuit (HP:0007772) | 1.88102734 |
| 152 | Enlarged kidneys (HP:0000105) | 1.88030687 |
| 153 | Confusion (HP:0001289) | 1.86550342 |
| 154 | Diplopia (HP:0000651) | 1.86107628 |
| 155 | Abnormality of binocular vision (HP:0011514) | 1.86107628 |
| 156 | Abnormal gallbladder physiology (HP:0012438) | 1.85922018 |
| 157 | Cholecystitis (HP:0001082) | 1.85922018 |
| 158 | Abnormality of the gallbladder (HP:0005264) | 1.85692144 |
| 159 | Widely spaced teeth (HP:0000687) | 1.84662022 |
| 160 | Vomiting (HP:0002013) | 1.83883434 |
| 161 | Sclerocornea (HP:0000647) | 1.83200119 |
| 162 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82627544 |
| 163 | Rectal prolapse (HP:0002035) | 1.81604310 |
| 164 | Renovascular hypertension (HP:0100817) | 1.81589763 |
| 165 | Abnormality of the ischium (HP:0003174) | 1.81242856 |
| 166 | Status epilepticus (HP:0002133) | 1.80528182 |
| 167 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.79223637 |
| 168 | Increased purine levels (HP:0004368) | 1.79165797 |
| 169 | Hyperuricemia (HP:0002149) | 1.79165797 |
| 170 | Abnormal number of erythroid precursors (HP:0012131) | 1.78418215 |
| 171 | Amyloidosis (HP:0011034) | 1.78337485 |
| 172 | Hemorrhage of the eye (HP:0011885) | 1.77972043 |
| 173 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.77842108 |
| 174 | Abnormal cartilage morphology (HP:0002763) | 1.76683251 |
| 175 | Back pain (HP:0003418) | 1.75601009 |
| 176 | Decreased central vision (HP:0007663) | 1.75282884 |
| 177 | Cerebral edema (HP:0002181) | 1.74636695 |
| 178 | Abnormal albumin level (HP:0012116) | 1.74014244 |
| 179 | Hypoalbuminemia (HP:0003073) | 1.74014244 |
| 180 | Rickets (HP:0002748) | 1.73795393 |
| 181 | Ulnar claw (HP:0001178) | 1.73435686 |
| 182 | Intellectual disability, severe (HP:0010864) | 1.72880434 |
| 183 | Absent speech (HP:0001344) | 1.72424094 |
| 184 | Dysmetric saccades (HP:0000641) | 1.71344559 |
| 185 | Stroke (HP:0001297) | 1.70814564 |
| 186 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70260941 |
| 187 | Absent thumb (HP:0009777) | 1.69585487 |
| 188 | Polyuria (HP:0000103) | 1.69572351 |
| 189 | Death in childhood (HP:0003819) | 1.68937673 |
| 190 | Pachygyria (HP:0001302) | 1.67216422 |
| 191 | Abnormality of the carotid arteries (HP:0005344) | 1.67087659 |
| 192 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.66725549 |
| 193 | Congenital hepatic fibrosis (HP:0002612) | 1.65917653 |
| 194 | Stomach cancer (HP:0012126) | 1.65277923 |
| 195 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.60421873 |
| 196 | Anencephaly (HP:0002323) | 1.59341334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.45963509 |
| 2 | ACVR1B | 4.45783460 |
| 3 | BCKDK | 4.15037540 |
| 4 | TAOK3 | 4.03391657 |
| 5 | INSRR | 3.87769135 |
| 6 | SIK1 | 3.79506880 |
| 7 | ADRBK2 | 3.62065930 |
| 8 | BMPR1B | 3.40462542 |
| 9 | TRIB3 | 3.13444026 |
| 10 | TLK1 | 3.01834078 |
| 11 | FGFR4 | 3.00946925 |
| 12 | PKN2 | 2.94002647 |
| 13 | PTK6 | 2.28094622 |
| 14 | ZAK | 2.26695659 |
| 15 | MAP2K4 | 2.22379374 |
| 16 | FRK | 1.96527160 |
| 17 | GRK1 | 1.85857026 |
| 18 | TGFBR1 | 1.78732102 |
| 19 | ERBB4 | 1.72763592 |
| 20 | LATS1 | 1.70005141 |
| 21 | AKT3 | 1.69993397 |
| 22 | FLT3 | 1.66838860 |
| 23 | MST1R | 1.57866663 |
| 24 | MAP3K7 | 1.52188331 |
| 25 | PIK3CA | 1.48092989 |
| 26 | MAP3K6 | 1.45292108 |
| 27 | CAMKK2 | 1.41895693 |
| 28 | ADRBK1 | 1.39743452 |
| 29 | MAPK11 | 1.39260552 |
| 30 | DAPK2 | 1.34540845 |
| 31 | STK39 | 1.34334479 |
| 32 | MAP2K3 | 1.31637387 |
| 33 | OXSR1 | 1.30786143 |
| 34 | TYRO3 | 1.28439781 |
| 35 | PNCK | 1.21579492 |
| 36 | SGK3 | 1.19184240 |
| 37 | TYK2 | 1.18612935 |
| 38 | WNK1 | 1.18031449 |
| 39 | CASK | 1.14753052 |
| 40 | JAK2 | 1.13861939 |
| 41 | MAPK15 | 1.12207168 |
| 42 | MAPK13 | 1.11345386 |
| 43 | MAP3K10 | 1.10390129 |
| 44 | RPS6KA6 | 1.09543032 |
| 45 | ITK | 1.07331290 |
| 46 | PDGFRA | 1.07091514 |
| 47 | NTRK3 | 1.05513999 |
| 48 | RET | 1.04651682 |
| 49 | PTK2 | 1.02786836 |
| 50 | JAK1 | 1.01959635 |
| 51 | EEF2K | 1.01610911 |
| 52 | MAP2K2 | 1.01271672 |
| 53 | DYRK1B | 0.99195721 |
| 54 | MKNK2 | 0.98696461 |
| 55 | MARK1 | 0.98438760 |
| 56 | PINK1 | 0.95742989 |
| 57 | MAP2K6 | 0.94941970 |
| 58 | STK11 | 0.94348712 |
| 59 | SGK2 | 0.93764275 |
| 60 | PIK3CG | 0.93551457 |
| 61 | PRKCH | 0.92523203 |
| 62 | MAP3K1 | 0.89765857 |
| 63 | JAK3 | 0.89276383 |
| 64 | TRPM7 | 0.88631200 |
| 65 | MAP3K2 | 0.86909579 |
| 66 | GRK6 | 0.86256949 |
| 67 | BMX | 0.85834789 |
| 68 | MAP3K14 | 0.80030496 |
| 69 | NEK2 | 0.79102486 |
| 70 | EPHB1 | 0.79032351 |
| 71 | RPS6KA5 | 0.78279454 |
| 72 | FGFR2 | 0.78238658 |
| 73 | PRKAA2 | 0.75745595 |
| 74 | STK3 | 0.75644220 |
| 75 | FGFR3 | 0.75542659 |
| 76 | MELK | 0.75174968 |
| 77 | MAP4K1 | 0.74518259 |
| 78 | PRKAA1 | 0.74429732 |
| 79 | TIE1 | 0.72707661 |
| 80 | CDK6 | 0.72675429 |
| 81 | MTOR | 0.71782085 |
| 82 | ZAP70 | 0.71557226 |
| 83 | PRKCZ | 0.69509612 |
| 84 | PRKCG | 0.69300722 |
| 85 | NEK9 | 0.68271729 |
| 86 | CAMK1 | 0.66970613 |
| 87 | EPHA2 | 0.66918457 |
| 88 | NTRK2 | 0.66723394 |
| 89 | MAP3K5 | 0.65862814 |
| 90 | ERBB2 | 0.65707256 |
| 91 | MAPKAPK5 | 0.64518934 |
| 92 | PTK2B | 0.63296823 |
| 93 | MAP2K1 | 0.63231060 |
| 94 | MAPK7 | 0.62456140 |
| 95 | RIPK1 | 0.62377006 |
| 96 | TNIK | 0.61130610 |
| 97 | MAPK12 | 0.61087545 |
| 98 | STK38L | 0.60249074 |
| 99 | IRAK1 | 0.59311264 |
| 100 | MET | 0.59175735 |
| 101 | CDC42BPA | 0.58638127 |
| 102 | ICK | 0.58554175 |
| 103 | CAMK4 | 0.58085825 |
| 104 | PRKCQ | 0.56972081 |
| 105 | KIT | 0.55178679 |
| 106 | PKN1 | 0.53935206 |
| 107 | IKBKB | 0.53210302 |
| 108 | MAP3K4 | 0.52979927 |
| 109 | HIPK2 | 0.52287302 |
| 110 | CHUK | 0.52018672 |
| 111 | PAK3 | 0.51247409 |
| 112 | SGK494 | 0.51062030 |
| 113 | SGK223 | 0.51062030 |
| 114 | CSK | 0.50993468 |
| 115 | PRKD2 | 0.50798035 |
| 116 | CAMK1D | 0.50754884 |
| 117 | TBK1 | 0.50439415 |
| 118 | PRKACG | 0.50434761 |
| 119 | FER | 0.50381546 |
| 120 | NLK | 0.50299948 |
| 121 | WNK3 | 0.49949109 |
| 122 | IRAK4 | 0.49352759 |
| 123 | MARK2 | 0.48167000 |
| 124 | NTRK1 | 0.48005708 |
| 125 | CDK12 | 0.47353544 |
| 126 | MAP3K11 | 0.47244369 |
| 127 | GSK3A | 0.45672918 |
| 128 | WNK4 | 0.44166565 |
| 129 | MAP3K3 | 0.43984925 |
| 130 | CAMKK1 | 0.43860137 |
| 131 | PRKD3 | 0.43686435 |
| 132 | IGF1R | 0.43498573 |
| 133 | EPHB2 | 0.43240818 |
| 134 | MAPK4 | 0.43157987 |
| 135 | MAPKAPK3 | 0.41986799 |
| 136 | SIK2 | 0.41661215 |
| 137 | PDPK1 | 0.41503713 |
| 138 | CAMK1G | 0.41233381 |
| 139 | STK38 | 0.40798243 |
| 140 | EPHA3 | 0.39807076 |
| 141 | SYK | 0.39146310 |
| 142 | SCYL2 | 0.38410463 |
| 143 | KSR2 | 0.38149019 |
| 144 | NUAK1 | 0.38108478 |
| 145 | PDGFRB | 0.36556559 |
| 146 | MAP3K13 | 0.36236346 |
| 147 | CHEK2 | 0.35240709 |
| 148 | RPS6KA2 | 0.34705506 |
| 149 | MUSK | 0.34660800 |
| 150 | TNK2 | 0.34024247 |
| 151 | PHKG2 | 0.33281782 |
| 152 | PHKG1 | 0.33281782 |
| 153 | SIK3 | 0.31839790 |
| 154 | MAPK8 | 0.31822541 |
| 155 | FGFR1 | 0.31456375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39550431 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.68050517 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53655662 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34816821 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.18034603 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.90511411 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.80336495 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53846381 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50708192 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49911649 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39310584 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39014195 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31842811 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18779240 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.18065520 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 2.16900070 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15058293 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.12955012 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.99770980 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.97193789 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91159802 |
| 22 | * Peroxisome_Homo sapiens_hsa04146 | 1.89016034 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88017666 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84412849 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.83514095 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.82922968 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82328948 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.80523196 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.74247074 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72847812 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.72414113 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.68936799 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66575126 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66312734 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65559185 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.64191325 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63638808 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60609927 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59406148 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58009976 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56545652 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 1.54271054 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52469869 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48638556 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46506209 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.44543662 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35027674 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33535227 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.32769398 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31863332 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29866746 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29419165 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.23619729 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20033798 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18071430 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17425660 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 1.14182724 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11997612 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11675947 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09176739 |
| 61 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.08332917 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.06350040 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04252276 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04200935 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02159050 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00911458 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 1.00003235 |
| 68 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99569377 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98361104 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98021775 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95664185 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94361996 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.88445838 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87219926 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86732919 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84770700 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84104819 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.82871839 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81149937 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79799578 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.79219785 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78197272 |
| 83 | Long-term depression_Homo sapiens_hsa04730 | 0.73241778 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69776794 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69753630 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69645837 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66260777 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64689601 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64052848 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63883290 |
| 91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62896707 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62608354 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.60887840 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60603791 |
| 95 | Asthma_Homo sapiens_hsa05310 | 0.60376013 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58858959 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56295381 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55819363 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52092642 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50046243 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49254581 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48161979 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47088322 |
| 104 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46031703 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45744234 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45002470 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44850598 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44314809 |
| 109 | RNA polymerase_Homo sapiens_hsa03020 | 0.43047161 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43012096 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42549257 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39590052 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.38833923 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37639289 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37578352 |
| 116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36337070 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36055243 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35814040 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.34530487 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33669723 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33355361 |
| 122 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32168015 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.31919344 |
| 124 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.31913023 |
| 125 | Renin secretion_Homo sapiens_hsa04924 | 0.31585085 |
| 126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30525883 |
| 127 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.30456180 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30220962 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28760825 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28626436 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28394930 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24871471 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24257244 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22791249 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20113762 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19038199 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.17310541 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15912804 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15757917 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11850149 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.08078148 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.05194317 |
| 143 | Circadian rhythm_Homo sapiens_hsa04710 | 0.04600698 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.03987400 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.01265083 |
| 146 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1025709 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | -0.0809548 |
| 148 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0744429 |
| 149 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0739453 |
| 150 | Lysosome_Homo sapiens_hsa04142 | -0.0669062 |
| 151 | Insulin secretion_Homo sapiens_hsa04911 | -0.0589448 |
| 152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0426422 |
| 153 | Bladder cancer_Homo sapiens_hsa05219 | -0.0366287 |
| 154 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0363590 |
| 155 | Hepatitis C_Homo sapiens_hsa05160 | -0.0265815 |
| 156 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0145534 |

